Table 5.
Methods used for the extraction and determination of the analyzed compounds.
| Common Name | Extraction Technique/Sorbent | Determination Method | Level (µg L−1) |
Reference |
|---|---|---|---|---|
| Diclofenac | SPE/polymer | LC-MS/MS | 2.0–6.30 0.91–1.90 0.18–2.60 |
[148] |
| SPE/hydrophilic-lipophilic polymer | LC-MS | 0.116 | [149] | |
| SPE/hydrophilic-lipophilic polymer | LC-MS | 0.113–4.882 | [150] | |
| Ibuprofen | SPE/ hydrophilic-lipophilic polymer |
LC-MS/MS | 27.30 | [151] |
| Ketoprofen | SPE/ hydrophilic-lipophilic polymer |
LC-MS | 0.031–3.511 | [150] |
| Naproxen | SPE/ hydrophilic-lipophilic polymer |
LC-MS | 22.50 | [149] |
| SPE/ hydrophilic-lipophilic polymer |
LC-MS/MS | 19.90 | [151] | |
| Erythromycin | SPE/ hydrophilic-lipophilic polymer |
LC-MS | 0.509–0.149 | [152] |
| SPE/ hydrophilic-lipophilic polymer |
LC-MS/MS | 0.785 | [153] | |
| Sulphamethoxazole | SPE/polymer | LC-MS | 0.376–0.572 | [154] |
| SPE/ hydrophilic-lipophilic polymer |
LC-MS | 2.060 | [149] | |
| SPE/ hydrophilic-lipophilic polymer |
LC-MS/MS | 0.024 | [153] | |
| Tetracycline | SPE /hydrophilic-lipophilic polymer |
LC-MS | 146.0 | [155] |
| Trimethoprim | SPE /hydrophilic-lipophilic polymer |
LC-MS/MS | 0.007 | [156] |
| SPE/ polymer |
LC-MS | 0.27–0.94 | [154] | |
| SPE /hydrophilic-lipophilic polymer |
LC-MS | 1.140 | [149] |